![Manish Singh](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Manish Singh
Plus aucun poste en cours
Profil
Manish Singh was the founder of Aliva Biopharmaceuticals, Inc. founded in 2006, where he held the title of Chief Executive Officer in 2007.
He was also a Director at California Technology Ventures from 2003 to 2007.
Dr. Singh's former jobs include being the President, CEO & Independent Director at ImmunoCellular Therapeutics Ltd. from 2008 to 2012, Chief Executive Officer at Iovance Biotherapeutics, Inc. in 2014, Principal at Cell Genesys, Inc., Manager at Genetic Therapy, Inc., and Manager at Chiron Viagene, Inc. Dr. Singh's education history includes an MBA from the University of California, Los Angeles, a graduate degree from Worcester Polytechnic Institute, and an undergraduate degree from Indian Institute of Technology Roorkee.
Anciens postes connus de Manish Singh
| Sociétés | Poste | Fin |
|---|---|---|
| IOVANCE BIOTHERAPEUTICS, INC. | Directeur Général | 31/12/2014 |
| EOM PHARMACEUTICALS HOLDINGS, INC. | President | 20/08/2012 |
California Technology Ventures
 California Technology Ventures Investment ManagersFinance California Technology Ventures in companies located in the United States. The firm focuses on a broad range of sectors and industries. It participates in seed, early and later stage capital requirements with an investment size of USD 0.25 - USD 2 million and invests up to USD 5 million over the life of the investment. | Private Equity Investor | 31/12/2007 |
Aliva Biopharmaceuticals, Inc.
 Aliva Biopharmaceuticals, Inc. Pharmaceuticals: GenericHealth Technology Develops animal systems for accurate prediction in human drug profiling | Fondateur | 01/12/2007 |
Cell Genesys, Inc.
 Cell Genesys, Inc. Pharmaceuticals: MajorHealth Technology Develops human disease therapies based on innovative gene modification technologies | Corporate Officer/Principal | - |
Formation de Manish Singh
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
19
Relations au 1er degré
10
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 10 |
|---|---|
Cell Genesys, Inc.
Cell Genesys, Inc. Pharmaceuticals: MajorHealth Technology Develops human disease therapies based on innovative gene modification technologies | Health Technology |
ImmunoCellular Therapeutics Ltd.
 ImmunoCellular Therapeutics Ltd. BiotechnologyHealth Technology Operates as a clinical stage pharmaceutical company | Health Technology |
Genetic Therapy, Inc.
 Genetic Therapy, Inc. Miscellaneous Commercial ServicesCommercial Services Develops human gene therapy delivery products | Commercial Services |
Chiron Viagene, Inc.
 Chiron Viagene, Inc. Miscellaneous Commercial ServicesCommercial Services Commercial biotechnical research | Commercial Services |
University of California, Los Angeles
 University of California, Los Angeles Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Worcester Polytechnic Institute
 Worcester Polytechnic Institute Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
California Technology Ventures
California Technology Ventures Investment ManagersFinance California Technology Ventures in companies located in the United States. The firm focuses on a broad range of sectors and industries. It participates in seed, early and later stage capital requirements with an investment size of USD 0.25 - USD 2 million and invests up to USD 5 million over the life of the investment. | Finance |
Indian Institute of Technology Roorkee
 Indian Institute of Technology Roorkee Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Aliva Biopharmaceuticals, Inc.
Aliva Biopharmaceuticals, Inc. Pharmaceuticals: GenericHealth Technology Develops animal systems for accurate prediction in human drug profiling | Health Technology |
Iovance Biotherapeutics, Inc.
 Iovance Biotherapeutics, Inc. BiotechnologyHealth Technology Develops biotechnological products for the treatment of cancer | Health Technology |
Choisissez Zonebourse 
